↓ Skip to main content

CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma

Overview of attention for article published in Journal of Hematology & Oncology, June 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
5 X users
patent
1 patent

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
119 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
Published in
Journal of Hematology & Oncology, June 2020
DOI 10.1186/s13045-020-00913-2
Pubmed ID
Authors

Kyle B. Lupo, Sandro Matosevic

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 119 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 17%
Researcher 19 16%
Student > Bachelor 17 14%
Student > Master 8 7%
Other 5 4%
Other 12 10%
Unknown 38 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 29 24%
Medicine and Dentistry 15 13%
Immunology and Microbiology 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Agricultural and Biological Sciences 3 3%
Other 12 10%
Unknown 46 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2023.
All research outputs
#5,329,699
of 25,002,811 outputs
Outputs from Journal of Hematology & Oncology
#440
of 1,274 outputs
Outputs of similar age
#120,001
of 404,826 outputs
Outputs of similar age from Journal of Hematology & Oncology
#21
of 44 outputs
Altmetric has tracked 25,002,811 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,274 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.4. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 404,826 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.